![2024 PDAFDA 2024 PDA/FDA Joint Regulatory Conference](/images/default-source/default-album/conferences/2024/pda-fda-joint-regulatory/2024-pdafda.jpg?sfvrsn=c2c871b7_3)
Andrea Karpinecz MS Iovance Biotherapeutics
![Andrea Karpinecz MS Andrea Karpinecz MS](https://pda.org/images/default-source/speaker-photos/andrea-karpinecz-ms-2438941.jpeg.jpeg?sfvrsn=79e7f5b3_0)
Andrea Karpinecz MS Iovance Biotherapeutics Vice President of Quality Control
Andrea Karpinecz is the Vice President of Quality Control at Iovance Biotherapeutics. Prior to Iovance Biotherapeutics, Ms. Karpinecz was the Senior Director of Quality Control for Bristol-Myers Squibb Cell Therapy where she led the teams responsible for performing all quality control testing for two commercially approved CAR-T cell therapies. Ms. Karpinecz has over 15 years of quality control experience in GMP cell therapy manufacturing, and she has supported regulatory submissions for six cell therapy products. Ms. Karpinecz earned a Bachelors of Science in Biotechnology from Rutgers University and a Masters of Science in Molecular Biology from Montclair State University.